Ipsos Healthcare, the global healthcare division of Ipsos, has launched the Hidradenitis Suppurativa (HS) Therapy Monitor in the EU5. The HS Monitor, part of Ipsos’ Autoimmune Real World Evidence portfolio, launched in the EU5 in Q2 of 2017, with plans to extend to other markets.
Upper middle class Russians name as their top goals for a year travel, a healthy lifestyle and renovation of an apartment, a house or country house (dacha).
Building on the huge success of its previous regional syndicated study, “She Speaks”, Ipsos Marketing in MENA is launching a new syndicated study, this time targeting one of the most important and most disruptive consumer segments in the region: Millennials.
We all know that MENA is one of the fastest growing online markets in the world, with number of internet users almost doubling every 5 years. The marketers are taking this opportunity and constantly increasing their share of media mix on digital, some reaching close to 30% of their total spends. But the question now is “are we getting enough return on our investment?”
Ipsos Healthcare has extended its syndicated Psoriasis and IBD Therapy Monitors into China. It will also re-launch the Lupus Therapy Monitor in China due to increased client demand
Overall number of outbound tourists in Russia decreased almost twice within past three years. But improvement in ecomical indicators gives hope to see revival of outbound tourism in 2017.
Deployed successfully, social listening can accelerate insight generation from any kind of text data: web forums, social media sites, survey verbatims, internal data, and much more.
Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.
